Schedule 13G ownership disclosure
Aptevo Therapeutics Inc.
Security class unavailable · CUSIP: 03835L108
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 457,272
- Percent of class
- 2.2000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000215457-17-003429
- Form type
- SC 13G
- Filer
- Aptevo Therapeutics Inc.
- CIK
- CIK 1671584
- Filed
- Jul 10, 2017
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership